The CCRCB Drug Discovery lab is focused on the development of highly potent, selective and drug-like lead compounds for the treatment of human diseases.
Working for PIs in the University we have developed a number of small molecule protease inhibitor tool compounds, that are currently being utilized to validate their target proteins as bone-fide drug targets.
Dr Williams is available to supervise the following projects;
MRes project: Development of Novel Cathepsin V inhibitors to Validate role in Breast Cancer
MRes project: Testing of Epigenetic Probes in Cancer Immune Cells
MRes project: Design, synthesis and SAR exploration of Novel LSD1 inhibitors